Baszucki Group directs resources toward the greater good through mission-driven investments that improve human health and the health of our planet.
Joined August 2022
- Tweets69
- Following6
- Followers1.3K
- Likes40
Today we introduce the Global Network for the Advancement of Metabolic Psychiatry, MetPsy, built for researchers and clinicians dedicated to advancing metabolic interventions in mental health.
MetPsy gives the global community one place to find collaborators, access shared best practices and training, and follow the latest research. It also offers funders a clear entry point to support the field as it moves from promising studies to clinical implementation.
The launch coincides with a $20 million grant from Baszucki Group to establish the McLean Center for Metabolic Psychiatry at @McLeanHospital, a member of Mass General Brigham. A defining initiative for the field, the Center will combine research, clinical practice, and specialized training to deliver metabolic approaches in psychiatric care at scale, a model we hope will set the stage for others to follow.
Discover and join: metpsy.co/4yvPTpK
Read the press release: bwnews.pr/4BBeixh
A new study funded by Baszucki Group is bringing an innovative mental health model to resource-poor rural areas.
Led by Dr. Will Rutland, researchers at @UABHeersink are launching a new study in partnership with a local food bank and @HatchforHunger to deliver ketogenic food boxes to participants with bipolar disorder.
This community-based approach allows ketogenic therapy to be introduced alongside existing treatment modalities, with the goal of expanding care options in rural areas that experience severe shortages in psychiatric care.
“This study reflects something we deeply believe: that the communities with the greatest need should have access to the most promising treatments,” said Julie Milder, PhD, Director of Neuroscience at Baszucki Group. “Dr. Rutland and his team are proposing a model that takes equity seriously — using existing community infrastructure to conduct rigorous research within a population that is historically underrepresented in clinical research.”
Read more about how Dr. Rutland and his team are pioneering equity in clinical research: bit.ly/4jWLSaf
This week, members of the Baszucki Group team attended The Ketogenic Foundation’s inaugural conference, which highlighted emerging research and clinical applications in metabolic health and nutritional ketosis.
The program brought together leading scientists and clinicians exploring ketogenic therapies across a range of complex chronic conditions, including type 1 and type 2 diabetes, cardiovascular disease, obesity, and neurodegenerative disorders such as Alzheimer’s disease.
Metabolic psychiatry was prominently featured, with @GeorgiaEdeMD sharing clinical insights, followed by @GuidoFrank, Mary Phillips, MD, and @ZSarnyai sharing research across anorexia nervosa, bipolar disorder, and schizophrenia. This led into an engaged panel discussion moderated by Baszucki Group’s Julie Milder, PhD.
The event showcased extraordinary cross-disciplinary collaboration and scientific momentum. We commend The Ketogenic Foundation and @BrittanieVolk for convening such an impactful conference, and we remain dedicated to advancing research and practice at the intersection of mental health and metabolism.
New research indicates that experiential training builds health care professionals’ readiness to implement ketogenic metabolic therapy in mental health care.
bit.ly/4hwBpzP
@ProfDeannaK at @UMmedschool piloted a program combining education with firsthand experience in ketogenic metabolic therapy for healthcare providers.
Participants reported significant improvements in self-reported competence and perceived ability to engage in shared decision-making. This is an early but promising step toward building the clinical infrastructure to meet the growing demand for metabolic therapies in mental healthcare.
Read the Baszucki Group funded study:
frontiersin.org/journals/psy…
Baszucki Group retweeted
“Metabolism is one of the biggest levers that we can use in improving our mental health.”
@NPR’s new Short Wave episode features @ShebaniMD on metabolic psychiatry, ketogenic metabolic therapy, and what this emerging field could mean for people living with conditions like schizophrenia, bipolar disorder, and depression.
Listen to the full interview here 👇
npr.org/2026/08/26/nx-s1-580…
We are encouraged to see the conversation around metabolic psychiatry continuing to gain momentum. On Thursday, August 20, from 2:00–3:30 PM ET, @samhsagov, a branch of the U.S. Dept. of Health and Human Services that works to improve mental health, is hosting a free, 1.5-CME/CEU-eligible webinar on metabolic psychiatry. You'll hear from Dr. Mark Frye, @ChrisPalmerMD, and @Radiantbeasting on emerging evidence in the field and how ketogenic therapy is being integrated into behavioral health care, with a moderated Q&A to follow.
Save your spot for this livestream event: zoom.us/webinar/register/WN_…
Baszucki Group retweeted
It's exciting to see more awareness building for metabolic psychiatry!
A recent @NatGeo article highlights the growing evidence and a powerful personal story from a member of our THINK+SMART community, Julianne Armijo.
“Within the first couple of weeks I noticed a difference,” Armijo says. “It was life-changing to realize instead of these high peaks and low valleys, I could have normal human changes in mood.”
Find links to the @NatGeo article (only available with a subscription) and Julianne Armijo's THINK+SMART profile below!
As metabolic psychiatry continues to gain ground, it's exciting to see @APApsychiatric make space for this important conversation on Thursday, August 20th. Dr. Mark Rapaport (@Pres_APA), @ShebaniMD, and Dr. Mahavir Agarwal will explore the emerging science and clinical implications during a fireside chat.
Register for this free, 1 CME credit-eligible event: bit.ly/3Sbp1wl
Join APA President Dr. Mark Rapaport as he leads the discussion on August 20th for the APA Looking Beyond webinar “Metabolic Psychiatry: Emerging Science and Equity Implications”.
Registration is free, 1 CME Credit Available.
ow.ly/buUV50ZvQk1
Baszucki Group retweeted
Standing room only for talks about nutrition science on Capitol Hill! It was an honor to join researchers, clinicians, policymakers, and advocates for The Power and Peril of Food: The Latest Science on Your Mood, Memory, Metabolism, and Longevity.
I am grateful to Dariush Mozaffarian, the Food Is Medicine Institute at Tufts University, and Food Tank for convening this important conversation on Capitol Hill about nutrition and health. I was able to share our son's story of recovery from mental illness using a nutritional metabolic therapy with policy makers who have the power to drive change. After a five-year battle with Bipolar I, our son has now been in remission for longer than he was ill.
Today's discussion reinforced an important reality: while philanthropy can help spark innovation, it cannot fund the scale of research needed to transform healthcare. That is why increased federal investment in nutrition science is so essential. We need the rigorous research that will give clinicians, patients, and families the evidence they deserve.
In 2024, a single serious mental illness, schizophrenia, burdened our country with $300 billion in societal costs. That is six times the NIH's annual research budget of $50 billion. And that doesn't count the emotional costs to families.
Can we, as a country, afford to NOT investigate dietary interventions with the potential to send mental illnesses like my son's--and many other chronic conditions--into remission?
Thank you to everyone working to advance this field. I'm encouraged by the growing momentum behind nutrition science and look forward to continuing this important work together.
If you missed the conversation, you can watch the livestream here: youtube.com/live/3JcV_SE6lek…
@tufts_fimi
@foodtank
@Metabolic_Mind
@metcoalition
#FoodTank #FoodIsMedicine #NutritionScience
New findings published today in Schizophrenia Bulletin report results from the first randomized controlled trial of ketogenic therapy in people living with psychotic disorders, offering encouraging early evidence.
Led by researchers at @UCSF, including Judith Ford, PhD, Samantha Abram, PhD, Juliette Kyner, and colleagues, the study enrolled participants with schizophrenia-spectrum or bipolar I disorders. The trial, partly funded by Baszucki Group, found rapid metabolic improvements with a ketogenic diet compared to diet-as-usual during an initial one-month open-label RCT phase. Participants who continued in the optional four-month extension saw additional gains across metabolic, psychiatric, and cognitive measures.
“This study adds to a growing body of evidence suggesting ketogenic therapy is a feasible and safe approach worth further investigation in serious mental illness,” said @janellison, co-founder and president of Baszucki Group. “Continued investment in rigorous scientific research will be important to better understand its potential and expand the scope of future studies.”
Read the press release: bit.ly/4pexA5F
Read the paper: doi.org/10.1093/schbul/sbag0…
Baszucki Group retweeted
Early research suggests that some mental health conditions could stem from metabolic disorders. If so, the findings could change how we treat mental illness
spklr.io/6018E3mEI
An important piece from Daniel Leckie, CEO of @HatchforHunger, in Newsweek.
newsweek.com/americas-charit…
Daniel shines a much-needed light on the critical role that true nutrition security, specifically reliable access to nutritious foods, including high-quality protein, plays in supporting long-term community health.
Baszucki Group applauds their efforts to elevate this national conversation and help build an infrastructure needed to get nutritious food to the communities that need it most.
It's been an exciting and informative week at the Keto Live conference in Switzerland!
The Baszucki Group team has been on the ground connecting with global pioneers to advance the science of metabolic health.
The event kicked off with an opening keynote from our very own @KirkNylen, PhD, who shared a comprehensive overview of "the distance traveled and the road ahead" from the Baszucki Group perspective, highlighting our global efforts to transform mental health treatments through metabolic interventions.
Programming also featured presentations by @ZSarnyai, @doncaloger0, @GuidoFrank, and other leading experts who dove deep into the powerful science and mechanisms behind ketogenic therapy.
We are proud to collaborate with this brilliant community as we pave the road ahead for metabolic psychiatry.
Baszucki Group retweeted
We were proud to fund this important pilot trial of a new metabolism-based treatment for Anorexia Nervosa. Please share with anyone who needs to know.
A study in Communications Medicine explores whether a special, fat-based diet could be a safe and effective treatment for adults with anorexia nervosa. Participants showed significant improvements in eating disorder symptoms. go.nature.com/4e9qNVP
ALT This is figure 3, which shows eating disorder and depression symptom scores over time.
A pilot study published today in @CommsMedicine demonstrates the potential for a new approach to treating anorexia nervosa. The research from @UCSDMedSchool, led by @GuidoFrank, reports that a ketogenic nutritional intervention was feasible and safe for patients with weight-normalized anorexia nervosa. Significant improvements were observed in eating disorder symptoms, with nearly 3 in 4 of study completers no longer meeting criteria for an anorexia nervosa diagnosis, and all completers experiencing an improvement in depression scores.
“This study highlights the promise of dietary interventions that target underlying neurometabolic dysfunction for even the most intractable psychiatric conditions like anorexia nervosa,” said @janellison, co-founder and president of Baszucki Group, which funded the study. “We hope this work drives awareness and support for researching and delivering ketogenic therapy for eating disorders, providing new hope for patients and their families.”
Read the paper: doi.org/10.1038/s43856-026-0…
Read the press release: bit.ly/49EQPyH
Learn more about the extension for the study for patients with both anorexia nervosa and bulimia nervosa: bit.ly/3PUK5WS
Baszucki Group retweeted
This will be the first time our son @matthewbaszucki and his dad @DavidBaszucki appear on a podcast together sharing Matt’s journey from being lost on the streets of LA deep in a manic episode to living the healthy, vibrant life he leads now.
Reliving some of this is harrowing, even now. But I hope this podcast will give others hope that healing is possible. Follow below so you don’t miss it when it drops next week.
It was an honour to host @DavidBaszucki (CEO of Roblox) and his son @matthewbaszucki - on a podcast together for the first time.
They walk through Matt's 5 years of severe, treatment-resistant bipolar I, the homelessness episode in LA, and how medically supervised ketogenic therapy eventually sent his symptoms into remission. 🧵